Vaxcyte Retained Earnings (Accumulated Deficit) 2019-2024 | PCVX
Vaxcyte retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-1.251B, a 68.27% increase year-over-year.
- Vaxcyte retained earnings (accumulated deficit) for 2023 were $-0.924B, a 77.04% increase from 2022.
- Vaxcyte retained earnings (accumulated deficit) for 2022 were $-0.522B, a 74.83% increase from 2021.
- Vaxcyte retained earnings (accumulated deficit) for 2021 were $-0.299B, a 50.4% increase from 2020.